Clinical trial · Observational
Bioelectrical Impedance Utilization and Dietary Intake Relation in the Breast Cancer Related Lymphedema
Relationship Between Bioelectrical Impedance Utilization and Dietary Intake in the Analysis of Risk of Lymphedema in Breast Cancer Survivors: A Prospective Cross Sectional Study
NCT03391206CI-TRIAL-00031051completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study was to investigate the clinical role of bioelectrical impedance analysis (BIA) and the relationship between the occurrence of breast cancer related lymphedema (BCRL) and dietary factors in breast cancer survivors who underwent surgical treatments.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Lymphedemas | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Inbody 720 | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- presence of BCRL
- description
- presence of breast cancer related lymphedema after surgical treatment using Inbody 720 and arm circumference measurement
- interventionNames
- Diagnostic Test: Inbody 720
- label
- absence of BCRL
- description
- absence of breast cancer related lymphedema after surgical treatment using Inbody 720 and arm circumference measurement
- interventionNames
- Diagnostic Test: Inbody 720
Primary outcomes (1)
- measure
- Brest cancer related lymphedema
- timeFrame
- At least six months after the surgical treatment
- description
- Assessed by measuring the circumference at 15.0 centimeter below the acromion process in both arm and circumference difference of greater than or equal to 2.0 centimeter.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Breast cancer patients * 20 years of age or older who survive after surgery and follow-up Exclusion Criteria: * Patients with bilateral breast cancer * Male breast cancer patient * Patients with a history of previous axillary surgery or radiation * Recurrent breast cancer subjects * Those who can not read or understand the written consent of an illiterate or foreigner * Subjects who did not voluntarily decide to participate in this study or who did not sign a consent form * The subjects who were judged inappropriate by the researcher to participate in this study
References
Publications (1)
- DERIVEDLim SM, Han Y, Kim SI, Park HS. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study. BMC Cancer. 2019 Jul 8;19(1):669. doi: 10.1186/s12885-019-5840-9. PMID 31286884